ArticleRMD open2026

Nerandomilast alleviates myositis-associated interstitial lung disease by modulating the non-Smad signalling pathway and activating the cAMP-PKA-RhoA pathway.

Xi Cui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.